Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rachel Toney"'
Publikováno v:
American Journal of Gastroenterology. 117:e2224-e2225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d77463d5c18e3429a9ca95c0959a38d
https://doi.org/10.14309/01.ajg.0000870816.71634.d2
https://doi.org/10.14309/01.ajg.0000870816.71634.d2
Autor:
Dianna Deweese, Renee Flannagan, Jordan Gladys-Oryhon, Robin Midian, Katie Farah, Paul Lebovitz, Elie Aoun, Bruce Bradley, Michael L. Mlecko, Hussam Kandil, Kenneth Glick, Ragunath Appasamy, Shyam Thakkar, Michael Babich, Shifa Umar, Abhijit Kulkarni, Heitham Abdul-Baki, Raktima Goswami, Marcia Mitre, Sandra El-Hachem, Akash Gadani, Gustavo Gomez, Gursimran Kochhar, Suzanne Morrissey, Irving Gottfried, Jose Oliva, Manish Dhawan, Payal Thakkar, Preethi Chintamaneni, Rachel Toney, Cristina Strahotin, Brian M. Parker, Rita Cole, Michelle Pfister, Susan Manzi, Aslam Syed, Jennifer Hadam
Publikováno v:
American Journal of Gastroenterology. 114:S140-S141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ece225ac22af6319562ef0bca9eb88e
https://doi.org/10.14309/01.ajg.0000590492.64337.57
https://doi.org/10.14309/01.ajg.0000590492.64337.57
Publikováno v:
Journal of Gastrointestinal Cancer. 50:960-961
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5a1ecea72e322aa7fba97c46c97f48
https://doi.org/10.1007/s12029-018-0143-y
https://doi.org/10.1007/s12029-018-0143-y
Publikováno v:
American Journal of Gastroenterology. 112:S1080-S1081
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da63787c26cf8bd9337b42f0ca6f79bc
https://doi.org/10.14309/00000434-201710001-01953
https://doi.org/10.14309/00000434-201710001-01953
Publikováno v:
Journal of Cutaneous Pathology. 30:591-595
Background: A new formulation of doxorubicin (pegylated liposomal doxorubicin) has been developed to attenuate the systemic side effects produced by this agent. Although pegylated liposomal doxorubicin has a much lower risk for cardiotoxicity, it has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a91e9984ca258174cb71e6e61d6f2ff6
https://doi.org/10.1034/j.1600-0560.2003.00113.x
https://doi.org/10.1034/j.1600-0560.2003.00113.x
Publikováno v:
Journal of cutaneous pathology. 30(9)
A new formulation of doxorubicin (pegylated liposomal doxorubicin) has been developed to attenuate the systemic side effects produced by this agent. Although pegylated liposomal doxorubicin has a much lower risk for cardiotoxicity, it has been associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71f748e3430aab2180a1f8929de2bedd
https://pubmed.ncbi.nlm.nih.gov/14507411
https://pubmed.ncbi.nlm.nih.gov/14507411